PL3054977T3 - Diagnoza i leczenie zespołu jelita drażliwego i choroby zapalnej jelit - Google Patents
Diagnoza i leczenie zespołu jelita drażliwego i choroby zapalnej jelitInfo
- Publication number
- PL3054977T3 PL3054977T3 PL14851688T PL14851688T PL3054977T3 PL 3054977 T3 PL3054977 T3 PL 3054977T3 PL 14851688 T PL14851688 T PL 14851688T PL 14851688 T PL14851688 T PL 14851688T PL 3054977 T3 PL3054977 T3 PL 3054977T3
- Authority
- PL
- Poland
- Prior art keywords
- diagnosis
- treatment
- inflammatory bowel
- bowel disease
- bowel syndrome
- Prior art date
Links
- 208000022559 Inflammatory bowel disease Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 208000002551 irritable bowel syndrome Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ecology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361888658P | 2013-10-09 | 2013-10-09 | |
| PCT/US2014/059957 WO2015054529A1 (en) | 2013-10-09 | 2014-10-09 | Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease |
| EP14851688.3A EP3054977B1 (en) | 2013-10-09 | 2014-10-09 | Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3054977T3 true PL3054977T3 (pl) | 2021-12-20 |
Family
ID=52813648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14851688T PL3054977T3 (pl) | 2013-10-09 | 2014-10-09 | Diagnoza i leczenie zespołu jelita drażliwego i choroby zapalnej jelit |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US9851361B2 (pl) |
| EP (1) | EP3054977B1 (pl) |
| JP (1) | JP6567509B2 (pl) |
| KR (1) | KR102259588B1 (pl) |
| CN (1) | CN105744956B (pl) |
| AU (2) | AU2014331841B2 (pl) |
| BR (1) | BR112016007474A2 (pl) |
| CA (1) | CA2923651C (pl) |
| CL (1) | CL2016000820A1 (pl) |
| ES (1) | ES2892905T3 (pl) |
| HK (1) | HK1221898A1 (pl) |
| IL (1) | IL244971B2 (pl) |
| MX (1) | MX2016004167A (pl) |
| NZ (1) | NZ717633A (pl) |
| PE (1) | PE20160882A1 (pl) |
| PL (1) | PL3054977T3 (pl) |
| PT (1) | PT3054977T (pl) |
| RU (1) | RU2683781C2 (pl) |
| SG (1) | SG11201601733VA (pl) |
| WO (1) | WO2015054529A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2396652B1 (en) | 2009-02-11 | 2017-12-13 | Cedars-Sinai Medical Center | Diagnosis of inflammatory bowel syndrome based on cytolethal distending toxin |
| US11693009B2 (en) | 2009-02-11 | 2023-07-04 | Cedars-Sinai Medical Center | Methods for detecting post-infectious irritable bowel syndrome |
| CA2884413C (en) | 2012-09-17 | 2022-11-01 | Cedars-Sinai Medical Center | Diagnosis and treatment of motility disorders of the gut and bladder, and of fibromyalgia |
| ES2892905T3 (es) | 2013-10-09 | 2022-02-07 | Cedars Sinai Medical Center | Diagnóstico y tratamiento del síndrome del intestino irritable y la enfermedad inflamatoria intestinal |
| KR102426541B1 (ko) | 2014-10-09 | 2022-07-29 | 세다르스-신나이 메디칼 센터 | 과민성 장 증후군을, 염증성 장 질환 및 셀리악 병과 구별하기 위한 방법 및 시스템 |
| CN106053827A (zh) * | 2016-05-17 | 2016-10-26 | 上海凯璟生物科技有限公司 | 一种肠易激综合症标志物Vinculin抗体检测试剂盒及其制备方法 |
| CN105784989A (zh) * | 2016-05-17 | 2016-07-20 | 上海凯璟生物科技有限公司 | 一种肠易激综合症标志物CdtB抗体检测试剂盒及其制备方法 |
| WO2017201461A1 (en) | 2016-05-20 | 2017-11-23 | Cedars-Sinai Medical Center | Diagnosis of inflammatory bowel disease based on genes |
| RU2763258C1 (ru) * | 2020-07-13 | 2021-12-28 | Евгения Николаевна Воронина | Способ дифференциальной диагностики воспалительных заболеваний кишечника у детей по комплексу клинико-анамнестических, лабораторных и инструментальных критериев |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691151A (en) * | 1994-10-07 | 1997-11-25 | Regents Of University Of California | Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca |
| US6562629B1 (en) | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| FR2806805A1 (fr) | 2000-03-22 | 2001-09-28 | Centre Nat Rech Scient | SEQUENCE PEPTIDIQUES COMPRENANT UN OU PLUSIEURS MOTIFS DE LIAISON AUX PROTEINES DE LA FAMILLE Ena/VASP, ET LEURS UTILISATIONS |
| AU2007201246B2 (en) | 2001-04-17 | 2008-12-04 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| AU2003233576A1 (en) * | 2002-05-17 | 2003-12-02 | Sugen, Inc. | Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals |
| EP1578364A4 (en) | 2002-09-16 | 2011-06-08 | Genentech Inc | COMPOSITIONS AND METHODS FOR TREATING IMMUNE DISEASES |
| US7595386B2 (en) | 2003-01-24 | 2009-09-29 | William Beaumont Hospital | Methods and compositions for heat activated gene therapy using cytolethal distending toxin |
| WO2004091622A1 (en) | 2003-04-08 | 2004-10-28 | Progenics Pharmaceuticals, Inc. | The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome |
| EP2280285A1 (en) * | 2003-09-15 | 2011-02-02 | Oklahoma Medical Research Foundation | Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases |
| CA2548381C (en) | 2003-12-05 | 2015-12-01 | Fuso Pharmaceutical Industries, Ltd. | Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target |
| US8148067B2 (en) | 2006-11-09 | 2012-04-03 | Xdx, Inc. | Methods for diagnosing and monitoring the status of systemic lupus erythematosus |
| WO2009082298A1 (en) | 2007-12-20 | 2009-07-02 | Index Diagnostics Ab | Method and kit for use in the differentiation of ibd and ibs and further distinction between disease types of ibd |
| KR101493125B1 (ko) | 2008-11-24 | 2015-02-12 | 세다르스-신나이 메디칼 센터 | 항산화성 캠토테신 유도체 및 이들의 항산화성 항종양성 나노구체 |
| US20110294726A1 (en) | 2009-02-11 | 2011-12-01 | Cedars-Sinai Medical Center | Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome |
| EP2396652B1 (en) | 2009-02-11 | 2017-12-13 | Cedars-Sinai Medical Center | Diagnosis of inflammatory bowel syndrome based on cytolethal distending toxin |
| FR2942541A1 (fr) | 2009-02-25 | 2010-08-27 | Assist Publ Hopitaux De Paris | Procede de diagnostic d'une vascularite |
| RU2397178C1 (ru) * | 2009-02-27 | 2010-08-20 | Федеральное государственное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | Диагностическая тест-система в формате иммуночипа и способ серологической дифференциальной диагностики сифилиса |
| IT1400989B1 (it) | 2010-07-13 | 2013-07-05 | Segix Italia S R L Ora Istituto Biochimico Naz Savio S R L | Forme di somministrazione orale a rilascio controllato di rifampicina per il trattamento di infezioni batteriche dell' apparato intestinale. |
| GB201017520D0 (en) | 2010-10-15 | 2010-12-01 | Sense Proteomic Ltd | Biomarkers |
| CA2884413C (en) | 2012-09-17 | 2022-11-01 | Cedars-Sinai Medical Center | Diagnosis and treatment of motility disorders of the gut and bladder, and of fibromyalgia |
| ES2892905T3 (es) | 2013-10-09 | 2022-02-07 | Cedars Sinai Medical Center | Diagnóstico y tratamiento del síndrome del intestino irritable y la enfermedad inflamatoria intestinal |
| KR102426541B1 (ko) | 2014-10-09 | 2022-07-29 | 세다르스-신나이 메디칼 센터 | 과민성 장 증후군을, 염증성 장 질환 및 셀리악 병과 구별하기 위한 방법 및 시스템 |
| CN106091069A (zh) | 2016-06-15 | 2016-11-09 | 安徽省绿巨人环境技术有限公司 | 一种废水再利用装置 |
| AU2018212924A1 (en) | 2017-01-30 | 2019-07-04 | Cedars-Sinai Medical Center | Diagnosis of scleroderma |
-
2014
- 2014-10-09 ES ES14851688T patent/ES2892905T3/es active Active
- 2014-10-09 CN CN201480055994.5A patent/CN105744956B/zh active Active
- 2014-10-09 JP JP2016521777A patent/JP6567509B2/ja active Active
- 2014-10-09 PL PL14851688T patent/PL3054977T3/pl unknown
- 2014-10-09 BR BR112016007474A patent/BR112016007474A2/pt active Search and Examination
- 2014-10-09 PE PE2016000430A patent/PE20160882A1/es unknown
- 2014-10-09 NZ NZ717633A patent/NZ717633A/en unknown
- 2014-10-09 CA CA2923651A patent/CA2923651C/en active Active
- 2014-10-09 EP EP14851688.3A patent/EP3054977B1/en active Active
- 2014-10-09 PT PT14851688T patent/PT3054977T/pt unknown
- 2014-10-09 WO PCT/US2014/059957 patent/WO2015054529A1/en active Application Filing
- 2014-10-09 SG SG11201601733VA patent/SG11201601733VA/en unknown
- 2014-10-09 US US15/021,850 patent/US9851361B2/en active Active
- 2014-10-09 IL IL244971A patent/IL244971B2/en unknown
- 2014-10-09 MX MX2016004167A patent/MX2016004167A/es unknown
- 2014-10-09 RU RU2016116766A patent/RU2683781C2/ru active
- 2014-10-09 AU AU2014331841A patent/AU2014331841B2/en active Active
- 2014-10-09 KR KR1020167011774A patent/KR102259588B1/ko active IP Right Grant
-
2016
- 2016-04-08 CL CL2016000820A patent/CL2016000820A1/es unknown
- 2016-08-19 HK HK16109934.2A patent/HK1221898A1/zh unknown
-
2017
- 2017-12-12 US US15/839,366 patent/US10352944B2/en active Active
-
2020
- 2020-05-27 AU AU2020203468A patent/AU2020203468A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3054977B1 (en) | 2021-07-21 |
| EP3054977A4 (en) | 2017-04-12 |
| BR112016007474A2 (pt) | 2017-09-12 |
| US10352944B2 (en) | 2019-07-16 |
| US20170038393A1 (en) | 2017-02-09 |
| KR102259588B1 (ko) | 2021-06-02 |
| PT3054977T (pt) | 2021-10-14 |
| WO2015054529A1 (en) | 2015-04-16 |
| AU2020203468A1 (en) | 2020-06-18 |
| US9851361B2 (en) | 2017-12-26 |
| JP2017502253A (ja) | 2017-01-19 |
| SG11201601733VA (en) | 2016-04-28 |
| PE20160882A1 (es) | 2016-09-14 |
| AU2014331841B2 (en) | 2020-03-12 |
| KR20160062161A (ko) | 2016-06-01 |
| RU2016116766A (ru) | 2017-11-15 |
| CL2016000820A1 (es) | 2016-09-23 |
| JP6567509B2 (ja) | 2019-08-28 |
| IL244971B2 (en) | 2023-12-01 |
| CA2923651C (en) | 2023-03-14 |
| CN105744956A (zh) | 2016-07-06 |
| IL244971B1 (en) | 2023-08-01 |
| RU2683781C2 (ru) | 2019-04-02 |
| CA2923651A1 (en) | 2015-04-16 |
| ES2892905T3 (es) | 2022-02-07 |
| IL244971A0 (en) | 2016-05-31 |
| CN105744956B (zh) | 2021-07-20 |
| NZ717633A (en) | 2021-07-30 |
| EP3054977A1 (en) | 2016-08-17 |
| AU2014331841A1 (en) | 2016-03-24 |
| US20180196063A1 (en) | 2018-07-12 |
| MX2016004167A (es) | 2016-06-24 |
| HK1221898A1 (zh) | 2017-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2971127A4 (en) | DIAGNOSTIC AND TREATMENT METHODS FOR INFLAMMATORY INTESTINAL DISEASE | |
| HK1221898A1 (zh) | 腸易激綜合徵和炎性腸病的診斷和治療 | |
| HK1220980A1 (zh) | 用於治療龐貝氏症的方法和組合物 | |
| EP2968397A4 (en) | DIAGNOSIS AND TREATMENT OF FIBROSIS | |
| HK1221422A1 (zh) | 診斷方法和用於治療成膠質細胞瘤的組合物 | |
| HK1219512A1 (zh) | 用於診斷和治療炎性腸病的方法 | |
| EP2958936A4 (en) | METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE | |
| IL275368B (en) | Diagnosis and treatment of autoimmune diseases | |
| FI3626270T3 (fi) | Sydän- ja verisuonitautien hoito | |
| ZA201408059B (en) | Compositions and methods for the treatment of inflammatory bowel disease | |
| EP3046629A4 (en) | Treatment of inflammatory skin disease | |
| EP2943593A4 (en) | DIAGNOSIS AND TREATMENT OF VIRUS DISEASES | |
| HK1222400A1 (zh) | 抗嗜酸細胞活化趨化因數抗體在治療炎症性腸病中的應用 | |
| EP3016968A4 (en) | Diagnosis and treatment of autoimmune diseases | |
| PL2870968T3 (pl) | Leczenie klinoptilolitem zapalnych chorób jelit | |
| HK1216150A1 (zh) | 匹多莫德治療炎症性腸病的用途 | |
| GB201318088D0 (en) | Oligonucleotide probe set and methods for the diagnosis of irritable bowel syndrome and inflammatory bowel disease | |
| HK1216151A1 (zh) | 匹多莫德治療腸易激綜合症的用途 | |
| GB201521918D0 (en) | Antibodies for treatment and diagnosis of inflammatory bowel disease | |
| GB201320014D0 (en) | Treatment of cardiovascular disease | |
| GB201321628D0 (en) | Treatment of disease | |
| AU2013902435A0 (en) | Diagnosis and treatment of autoimmune diseases | |
| GB201306411D0 (en) | Treatment of inflammatory conditions | |
| GB201301685D0 (en) | Diagnosis and treatment of cancer |